Trends in Insulin Use and Diabetes Control in the U.S.: 1988–1994 and 1999–2012

por Selvin, Elizabeth, Parrinello, Christina M., Daya, Natalie, Bergenstal, Richard M.
Publicado 2016

Advanced Technology in the Management of Diabetes: Which Comes First—Continuous Glucose Monitor or Insulin Pump?

por Martin, Christopher T., Criego, Amy B., Carlson, Anders L., Bergenstal, Richard M.
Publicado 2019

Addressing shortfalls of laboratory HbA(1c) using a model that incorporates red cell lifespan

por Xu, Yongjin, Bergenstal, Richard M, Dunn, Timothy C, Ajjan, Ramzi A
Publicado 2021

A Safe and Simple Algorithm for Adding and Adjusting Mealtime Insulin to Basal-Only Therapy

por Johnson, Mary L., Bergenstal, Richard M., Levy, Brian L., Dreon, Darlene M.
Publicado 2022

No Racial Differences in the Association of Glycated Hemoglobin With Kidney Disease and Cardiovascular Outcomes

por Selvin, Elizabeth, Rawlings, Andreea M., Bergenstal, Richard M., Coresh, Josef, Brancati, Frederick L.
Publicado 2013

Interindividual variability in average glucose‐glycated haemoglobin relationship in type 1 diabetes and implications for clinical practice

por Xu, Yongjin, Bergenstal, Richard M., Dunn, Timothy C., Ram, Yashesvini, Ajjan, Ramzi A.
Publicado 2022

Effects of Exenatide vs. Metformin on endothelial function in obese patients with pre-diabetes: a randomized trial

por Kelly, Aaron S, Bergenstal, Richard M, Gonzalez-Campoy, J Michael, Katz, Harold, Bank, Alan J
Publicado 2012

Efficacy and Safety of Taspoglutide Versus Sitagliptin for Type 2 Diabetes Mellitus (T-Emerge 4 Trial)

por Bergenstal, Richard M., Forti, Adriana, Chiasson, Jean-Louis, Woloschak, Michael, Boldrin, Mark, Balena, Raffaella
Publicado 2012

A1C predicts type 2 diabetes and impaired glucose tolerance in a population at risk: the community diabetes prevention project

por Leite, Silmara AO, Anderson, Robyn L, Kendall, David M, Monk, Arlene M, Bergenstal, Richard M
Publicado 2009

Low cardiorespiratory fitness in people at risk for type 2 diabetes: early marker for insulin resistance

por Leite, Silmara AO, Monk, Arlene M, Upham, Paul A, Chacra, Antonio R, Bergenstal, Richard M
Publicado 2009

Low-Volume Insulin Degludec 200 Units/mL Once Daily Improves Glycemic Control Similarly to Insulin Glargine With a Low Risk of Hypoglycemia in Insulin-Naïve Patients With Type 2 Di...

por Gough, Stephen C.L., Bhargava, Anuj, Jain, Rajeev, Mersebach, Henriette, Rasmussen, Søren, Bergenstal, Richard M.
Publicado 2013

Continuous Glucose Monitoring in Patients With Type 1 Diabetes Using Insulin Injections

por Foster, Nicole C., Miller, Kellee M., Tamborlane, William V., Bergenstal, Richard M., Beck, Roy W.
Publicado 2016

Abstract 4: Derived time-in-range is associated with major adverse cardiovascular event in T2D: Data from the DEVOTE trial

por Pathan, Muzammil Khan A, Bergenstal, Richard M, Hachmann-Nielsen, Elise, Kvist, Kajsa, Buse, John B
Publicado 2022

Assessing Time in Range with Postprandial Glucose-Focused Titration of Ultra Rapid Lispro (URLi) in People with Type 1 Diabetes

por Bergenstal, Richard M., Bode, Bruce W., Bhargava, Anuj, Wang, Qianqian, Knights, Alastair W., Chang, Annette M.
Publicado 2023

Adjust to Target in Type 2 Diabetes: Comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine

por Bergenstal, Richard M., Johnson, Mary, Powers, Margaret A., Wynne, Alan, Vlajnic, Aleksandra, Hollander, Priscilla, Rendell, Marc
Publicado 2008

Incretin-Based Therapies for the Treatment of Type 2 Diabetes: Evaluation of the Risks and Benefits

por Drucker, Daniel J., Sherman, Steven I., Gorelick, Fred S., Bergenstal, Richard M., Sherwin, Robert S., Buse, John B.
Publicado 2010

Ultra-Rapid Lispro Improves Postprandial Glucose Control and Time in Range in Type 1 Diabetes Compared to Lispro: PRONTO-T1D Continuous Glucose Monitoring Substudy

por Malecki, Maciej T., Cao, Dachuang, Liu, Rong, Hardy, Thomas, Bode, Bruce, Bergenstal, Richard M., Bue-Valleskey, Juliana
Publicado 2020

Flash CGM Is Associated With Reduced Diabetes Events and Hospitalizations in Insulin-Treated Type 2 Diabetes

por Bergenstal, Richard M, Kerr, Matthew S D, Roberts, Gregory J, Souto, Diana, Nabutovsky, Yelena, Hirsch, Irl B
Publicado 2021

Increased Derived Time in Range Is Associated with Reduced Risk of Major Adverse Cardiovascular Events, Severe Hypoglycemia, and Microvascular Events in Type 2 Diabetes: A Post Hoc...

por Bergenstal, Richard M., Hachmann-Nielsen, Elise, Kvist, Kajsa, Peters, Anne L., Tarp, Jens Magelund, Buse, John B.
Publicado 2023

Glycaemic control and hypoglycaemia during 12 months of randomized treatment with insulin glargine 300 U/mL versus glargine 100 U/mL in people with type 1 diabetes (EDITION 4)...

por Home, Philip D., Bergenstal, Richard M., Bolli, Geremia B., Ziemen, Monika, Rojeski, Maria, Espinasse, Melanie, Riddle, Matthew C.
Publicado 2017